Abstract:Genetic testing has been applied for decades in clinical routine diagnostics of hematological malignancies to improve disease (sub)classification, prognostication, patient management and survival. In recent classifications of hematological malignancies, disease subtypes are defined by key recurrent genetic alterations detected by conventional methods (i.e., cytogenetics, FISH, and targeted sequencing). Hematological malignancies were also one of the first disease areas in which targeted therapies were introduced, the prime example being BCR::ABL1 inhibitors, followed by an increasing number of targeted inhibitors hitting the Achilles' heel of each disease, resulting in a clear patient benefit. Owing to the technical advances in high‐throughput sequencing, we can now apply broad genomic tests, including comprehensive gene panels or whole‐genome and whole‐transcriptome sequencing, to identify clinically important diagnostic, prognostic and predictive markers. In this review, we give examples of how precision diagnostics have been implemented to guide treatment selection and improve survival in myeloid (myelodysplastic syndrome, acute myeloid leukemia) and lymphoid malignancies (acute lymphoblastic leukemia, diffuse large B cell lymphoma, chronic lymphocytic leukemia). We discuss the relevance and potential of monitoring measurable residual disease using ultra‐sensitive techniques to assess therapy response and detect early relapses. Finally, we bring up the promising avenue of functional precision medicine, combining ex vivo drug screening with various omics technologies, to provide novel treatment options for patients with advanced disease. Although we are only in the beginning of the field of precision hematology, we foresee rapid development with new types of diagnostics and treatment strategies becoming available to the benefit of our patients. This article is protected by copyright. All rights reserved

Equity in blood transfusion precision services

Quality Assessment of Established and Emerging Blood Components for Transfusion

Blood Bonds: Transforming Blood Donation Through Innovation, Inclusion, and Engagement

The future of blood services amid a tight balance between the supply and demand of blood products: Perspectives from the ISBT Young Professional Council

International blood collection and storage: Clinical use of blood products

An exploration of the influences on clinical decision making and the culture of blood transfusion practise in cancer-related anaemia using an ethnographic methodology

Blood and Blood Components: From Similarities to Differences

Assessment of stored red blood cells through lab-on-a-chip technologies for precision transfusion medicine

Translation strategies, contradiction, and the theory of social representations: Why discussing needles may improve blood donor retention

Calling for diversity: improving transfusion safety through high-throughput blood group microarray genotyping

Red Blood Cell Omics and Machine Learning in Transfusion Medicine: Singularity Is Near

Blood Transfusion in Equids—A Practical Approach and Review

Patient blood management and blood conservation - Complimentary concepts and solutions for blood establishments and clinical services in South Africa and beyond

Implementation of Patient Blood Management in Orthotopic Heart Transplants: A Single Centre Retrospective Observational Review

Precision Medicine: From Science To Value

Novel precision medicine approaches and treatment strategies in hematological malignancies

Steps Forward to a Fair and Inclusive Blood Supply

How anti-c in a D- patient prompted lifesaving work between a transfusion service and a blood center reference laboratory

Insights into the diversity of blood donation practice across Asia: How blood collection agencies adapt donor criteria and processes to their population

Precision medicine in Australia: indigenous health professionals are needed to improve equity for Aboriginal and Torres Strait Islanders

From Unit to Dose: A Machine Learning Approach for Precise Prediction of Hemoglobin and Iron Content in Individual Packed Red Blood Cell Units